Walnuts For Cancer?

Walnuts have been lauded as a ‘superfood’, containing a remarkable array of natural constituents that have synergistic properties that contribute to reduced cancer risk.  Mediated both directly and indirectly via its actions on the microbiome, many of the beneficial properties of walnuts are related to a range of anti-inflammatory properties, including powerful effects on the immune system.

Traditionally, walnuts have been known for their lipid profile, which has been linked to a wide array of biological properties and health-promoting effects. In addition to essential fatty acids, walnuts contain a variety of other bioactive compounds, such as vitamin E and polyphenols.   Among common foods and beverages, walnuts represent one of the most important sources of polyphenols, long recognized for their beneficial effect over human health.  Consequently, a plethora of reports has emerged on the potential role of walnut consumption against a series of diseases including cancer, gut dysbiosis, cardiovascular, and neurodegenerative diseases.

The Pub Med abstracts below address the ameliorative effects of a walnut-enriched diet in chronic diseases which can be attributed to the synergistic effects of walnut components, mainly through anti-oxidative and anti-inflammatory roles.

Does your oncologist have a bowl of walnuts in his waiting room?  How much time did he or she spend explaining the benefits of walnuts as a non-toxic cancer treatment?  Unfortunately, there is no economic incentive within our current healthcare system to offer this type of natural, effective treatment regimen, as opposed to, for example, the immunotherapy I was prescribed for my stage 4, metastatic cancer, which had a price tag of $33,000 a month!